Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


China Accepts IND Application For Eftansomatropin Pivotal Trial In Pediatric Patients With Growth Hormone Deficiency


RTTNews | Aug 4, 2020 08:19AM EDT

08:19 Tuesday, August 4, 2020 (RTTNews) - China Accepts IND Application For Eftansomatropin Pivotal Trial In Pediatric Patients With Growth Hormone Deficiency

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC